C-reactive protein; a potential marker of second cancer and cardiovascular disease in testicular cancer survivors? - ScienceDirect
C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review | PLOS ONE
Frontiers | C-Reactive Protein and Cancer—Diagnostic and Therapeutic Insights
Added value and cascade effects of inflammatory marker tests in UK primary care: a cohort study from the Clinical Practice Research Datalink | British Journal of General Practice
Odds ratios (ORs) and 95% confidence intervals for cancer by serum... | Download Table
Interpretation of lab tests - CRP, TUMOR MARKERS, SERUM FERRITIN
C-reactive protein and cancer risk: a pan-cancer study of prospective cohort and Mendelian randomization analysis | BMC Medicine | Full Text
Early cancer detection in the healthy dog | IVC Journal
Frontiers | Combination of Serum Amyloid A and C-Reactive Protein Exhibit Synergistic Effect in Angiogenesis by Inducing Inflammation and Vascular Network
C-reactive protein (CRP) test: High and low levels, and normal range
Interpretation of lab tests - CRP, TUMOR MARKERS, SERUM FERRITIN
C-reactive protein - Wikipedia
C-reactive protein and other biomarkers—the sense and non-sense of using inflammation biomarkers for the diagnosis of severe bacterial infection
A prospective follow-up study of the relationship between high-sensitivity C-reactive protein and primary liver cancer | BMC Cancer | Full Text
Prognostic Impact of a Novel Tumor Marker and Inflammation Index for Patients With Non-small-cell Lung Cancer | Anticancer Research
Predictive value of inflammatory markers for cancer diagnosis in primary care: a prospective cohort study using electronic health records | British Journal of Cancer
C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review.
C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review | PLOS ONE
Diagnosis Value of Combined Detection of Serum SF, CEA and CRP in Non- | CMAR
Inflammation and Lung Cancer Risk Qiuyin Cai Vanderbilt Epidemiology Center Vanderbilt University. - ppt download
Evaluation of CEA, CA19-9, CRP and leucocyte count as prognostic marker... | Download Scientific Diagram
Biology | Free Full-Text | Inflammatory Markers in Cancer Immunotherapy
